gold has been researched along with Cardiomegaly in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Q; Ju, F; Liu, Q; Liu, Y; Ma, Q | 1 |
| Li, Z; Qiao, Y; Tian, A; Zhu, B | 1 |
| Guo, L; Li, Z; Meng, Z; Nie, G; Tian, A; Tian, X; Wu, J; Xing, R; Yang, C; Yang, H; Zhang, Y | 1 |
| Li, Z; Tian, A; Yang, C | 1 |
| Jurik, AG; Møller, P | 1 |
| Burch, GE; Chu, KC; Colcolough, HL; Sohal, RS; Sun, SC | 1 |
| Calabro, JJ; Katz, RM; Maltz, BA | 1 |
1 review(s) available for gold and Cardiomegaly
| Article | Year |
|---|---|
A critical reappraisal of juvenile rheumatoid arthritis.
Topics: Agammaglobulinemia; Arthritis, Juvenile; Aspirin; Cardiomegaly; Child; Child, Preschool; Chloroquine; Exercise Therapy; Fever; Gold; Heart Failure; Home Care Services; Humans; Hypersensitivity; Indomethacin; Joints; Leukemia; Lupus Erythematosus, Systemic; Myocarditis; Pericarditis; Phenylbutazone; Prednisone; Prognosis; Purpura; Radiography; Rubella; Serum Sickness; Skin Manifestations; Splints; Synovial Fluid; Synovitis; Uveitis, Anterior; Vascular Diseases | 1971 |
6 other study(ies) available for gold and Cardiomegaly
| Article | Year |
|---|---|
In vivo evaluation of enhanced drug carrier efficiency and cardiac anti-hypertrophy therapeutic potential of nano-curcumin encapsulated photo-plasmonic nanoparticles combined polymerized nano-vesicles: A novel strategy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cardiomegaly; Combined Modality Therapy; Curcumin; Drug Liberation; Emulsions; Gold; Humans; Male; Metal Nanoparticles; Nanocapsules; Particle Size; Phototherapy; Polylactic Acid-Polyglycolic Acid Copolymer; Polymerization; Rats; Solvents | 2019 |
PEG-coated gold nanoparticles attenuate β-adrenergic receptor-mediated cardiac hypertrophy.
Topics: Adrenergic beta-Agonists; Animals; Cardiomegaly; Fibrosis; Gold; Heart; Interleukin-6; Isoproterenol; Male; MAP Kinase Signaling System; Mice, Inbred Strains; Myocardium; Nanoparticles; Polyethylene Glycols; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1 | 2017 |
No overt structural or functional changes associated with PEG-coated gold nanoparticles accumulation with acute exposure in the mouse heart.
Topics: Adrenergic beta-Agonists; Animals; Cardiomegaly; Cardiotoxins; Disease Models, Animal; Drug Delivery Systems; Fibrosis; Gold; Heart Ventricles; Isoproterenol; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Polyethylene Glycols; Random Allocation; Surface Properties; Tissue Distribution; Ventricular Function; Ventricular Remodeling | 2013 |
Reversible cardiac hypertrophy induced by PEG-coated gold nanoparticles in mice.
Topics: Animals; Biomarkers; Cardiomegaly; Coated Materials, Biocompatible; Cytokines; Disease Models, Animal; Fibrosis; Gold; Heart Function Tests; Inflammation; Inflammation Mediators; Metal Nanoparticles; Mice; Models, Biological; Myocardium; Particle Size; Polyethylene Glycols | 2016 |
Atrioventricular conduction time in rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Arthritis, Rheumatoid; Atrioventricular Node; Cardiomegaly; Chloroquine; Electrocardiography; Female; Gold; Heart Conduction System; Humans; Male; Middle Aged | 1985 |
Lipid cardiomyopathy of the hypertrophied heart of goldthioglucose obese mice.
Topics: Animals; Cardiomegaly; Glucose; Gold; Lipids; Mice; Microscopy, Electron; Myocardium; Obesity | 1969 |